Turning Point Brands 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Third-quarter consolidated net sales increased 27% year over year to $151 million, and gross profit increased 21% to $85 million.
- Gross margin was 56%, down slightly versus the second quarter when normalizing for the positive impact of the tariff refund.
- Adjusted EBITDA decreased 41% year over year to $18 million, reflecting increased sales and marketing investment, but rose $3 million, or 21%, sequentially.
- Modern Oral net sales increased 103% year over year to $74 million, while gross sales increased 114% to $94 million; Modern Oral accounted for 49% of consolidated net sales, up from 31% in Q3 2025.
- Stokers segment net sales increased 52% year over year to $114 million, driven by Modern Oral; heritage Stokers brand net revenue increased 3% to $39 million, while Stokers gross profit increased 42% to $64 million and gross margin decreased 416 basis points to 56%.
- Zigzag segment net sales decreased 15% year over year to $37 million, and gross profit decreased 16% to $21 million; gross margin was 57%, essentially unchanged from last year.
- Third-quarter free cash flow was $3.5 million, quarter-end cash was $251 million, and the company repurchased $10 million of stock.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
conference call. All participants will be in listen-only mode. All lines have been placed on mute to prevent any background noise. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Andrew Flynn, Chief Financial Officer. Please go ahead. Good morning, everyone.
Earlier today, we issued a press release covering our third quarter results, available in the investor relations section of our website at www.turningpointbrands.com. During this call, we'll discuss consolidated and segment operating results, the operating environment, and our progress against our strategic plan. Before we begin, please refer to the forward-looking statements and risk factors in our press release and SEC filings. We'll also reference certain non-GAAP financial measures. Reconciliations and explanations are included in today's earnings release. With that, I'll turn the call over to our CEO, David Glazek.
Thanks, Andrew, and good morning, everyone. Before discussing the results for the quarter, I'd first just like to say how excited I am to serve as the CEO of Turning Point Brands. As some of you know, I've been involved with the company for nearly 14 years, including the past four years as executive chairman, where I've worked closely with our leadership team on a daily basis. Over that time, I've had the pleasure of seeing firsthand the strength of our brands, the capabilities of our team, and our ability to adapt and capitalize on emerging opportunities. I'm incredibly proud of what we've accomplished to date and see tremendous potential in what lies ahead. Our strategy remains unchanged: investing cash flow from our heritage businesses to build leading brands in Modern Oral.
Our investments in brands, people, and capabilities will continue to be focused on maximizing the value of this transformational opportunity. Now turning to the third quarter results. We delivered another strong quarter led by Modern Oral. Consistent with our expectations, Modern Oral gross sales were up 114% year-over-year and 8% sequentially, while net sales were up 103% year-over-year and 9% sequentially. We're encouraged by the performance of both of our Modern Oral brands, FRE and ALP. We remain focused on continuing to build convenience store distribution, especially in chain accounts, where the majority of the category volume now resides. These chain placements are critical to establishing durable brands, expanding our consumer reach, and positioning FRE and ALP among the long-term leaders in the nicotine pouch category.
We expect our investments in distribution to differentiate FRE and ALP from smaller competitors and help create durable long-term annuity streams. In the quarter, Modern Oral accounted for 49% of our total revenue. That is up from 31% in Q3 2025. Our heritage businesses also performed well. Zig-Zag sales improved sequentially, and the Stoker's MST business continues to outperform the category. Now turning to our strategy. As we have communicated before, Modern Oral remains our primary growth driver. We are committed to making the investments necessary to build a leading position in the category. Our strategy is centered on three key priorities: gaining consumer traction, expanding distribution, and building the infrastructure that is necessary to scale. Importantly, we are seeing meaningful progress across each of these three priorities as we enter our next phase of growth. First, we have demonstrated that our brands resonate with consumers.
The success of FRE and ALP, particularly in the direct-to-consumer and independent retail channels, has validated our product quality and brand positioning. We are now seeing that traction translate into encouraging results in chain accounts, which further reinforces our confidence in the long-term potential of these brands. Secondly, we are expanding into the channels that matter most. We are making progress bringing FRE into larger regional and national chains, while ALP expansion into brick-and-mortar continues to gain momentum. We are on track to increase our chain store count by more than 70% during 2026. This reflects in large part the strength of our long-term retail partnerships. Chain account placements provide access to a significantly larger consumer base and establish the durable distribution footprint that is necessary to become one of the ubiquitously distributed brands in the category. Third, we are putting the infrastructure in place to support that growth.
Our investments in sales force expansion, retail execution, and domestic manufacturing are designed to support our expanding distribution footprint and improve operating efficiency over time. As we have scaled the distribution, we have continued investing in our sales force to service these new accounts. Our sales organization is critical to executing successfully at retail by ensuring product availability, merchandising execution, shelf placement, and ongoing customer support. We believe this growth is critical to growing share in the nicotine pouch category and should also benefit Zig-Zag and Stoker's going forward. Onshoring the supply chain remains an important driver of long-term profitability and a core strategic priority. As we have mentioned before, we currently expect U.S. manufacturing to commence in 2027. The progress we are making across these priorities reinforces my confidence in our strategy and highlights our ability to execute on the opportunities ahead.
As we continue to scale, we are focused on leveraging our expanded distribution footprint and growing brand momentum into sustainable revenue growth and profitability. I will now turn the call over to Summer to discuss our commercial progress.
Thank you, David, and good morning, everyone. We are encouraged by the progress we are making across our commercial initiatives as we expand the reach of FRE and ALP. Our approach is centered on creating a reinforcing cycle of growth. Broader distribution increases consumer access and trial. Growing demand drives repeat purchases and stronger in-store performance, and that success creates opportunities for further distribution expansion. We are beginning to see this dynamic take shape across both brands, reinforcing our confidence in our go-to-market strategies. Starting with commercial momentum, FRE continues to expand its presence across national retail chains while also securing broader product assortments within existing accounts. As David said, we are on track to increase our chain store count by more than 70% during 2026. Importantly, we are encouraged by the early performance of FRE in newly added locations, supported by our expanded sales coverage, merchandising, and shelf visibility.
For ALP, we are making progress expanding distribution across independent retailers and regional chains, with discussions among larger national chains beginning to take shape. Stepping back, we believe the strength of our two-brand portfolio is an important competitive advantage. FRE and ALP provide multiple avenues to reach consumers, expand distribution, and strengthen our overall position in the Modern Oral category. As we continue building both brands, we believe it is important to evaluate their combined momentum alongside their individual performance. Turning to marketing and brand building, we continue to leverage strategic partnerships, product innovation, and targeted campaigns to strengthen consumer awareness and engagement across our brands. For FRE, we are building on our existing TKO partnership to deepen consumer engagement and strengthen the brand's presence at retail. We are now beginning to incorporate partnership branding into our in-store merchandising, creating a more direct connection between our marketing initiatives and the point of purchase.
As our brands scale, we are also becoming more selective in how we allocate marketing resources. Programs that were valuable in early awareness may offer less relative impact today as larger opportunities emerge. We are applying those learnings to redirect investment toward initiatives with the greatest expected returns. Across both brands, we are taking a more customer-centric approach to innovation. Through FRE Labs, we are introducing limited-edition flavors and gathering direct feedback from adult consumers to help inform future product offerings. Similarly, ALP's new Frontier Collection introduced three of the brand's most requested flavors, supporting a broader marketing campaign. These initiatives reflect our focus on the individual consumer and brand engagement, and ultimately, our response to evolving preferences. In Zig-Zag, we remain focused on strengthening our core rolling papers business, accelerating growth in cones and wraps, and expanding brand relevance in priority markets.
Building on the momentum of our Life's Fast, Burn Slow platform, we are evolving our brand strategy beyond traditional advertising to drive cultural relevance and retail activation through strategic partnerships, targeted media investments, and consumer engagement. Our focus is on translating these investments into stronger in-store visibility, expanded distribution, and sustainable growth across the portfolio. Let me now turn the call over to Andrew to go through our financial results.
Thank you, Summer. Starting with consolidated results, net sales were up 27% year-over-year to $151 million for the quarter. Growth was driven primarily by Modern Oral. Gross profit of $85 million increased 21%, driven by Modern Oral. Gross margin was 56%, which was down slightly versus the second quarter when normalizing for the positive impact of the tariff refund. Reported SG&A was $75 million for the quarter, which was down almost $2 million sequentially. As discussed previously, our SG&A investments are designed to create long-term brand value. As we grow leading consumer brands, investments in our commercial team, marketing, sponsorships, and in-store merchandising are critical and flexible. We took advantage of this flexibility in Q3 and scaled back in areas where we thought the returns were inadequate. We will continue to assess the effectiveness of these initiatives and allocate capital towards the highest return opportunities.
Conversely, we can scale back spending and redeploy those resources towards the highest return. This flexibility gives us confidence to invest where we see momentum while maintaining disciplined capital deployment. Adjusted EBITDA was down 41% year-over-year to $18 million for the quarter. The decline was attributed to our strategy to increase sales and marketing investment. Adjusted EBITDA was up sequentially by $3 million or 21% due to higher gross profit and reduced SG&A. Moving to segment performance, beginning with Stoker's. Stoker's segment net sales increased 52% year-over-year to $114 million for the quarter. The Stoker's segment accounts for 75% of consolidated net sales. The growth was driven by Modern Oral nicotine pouch net sales, which increased 103% year-over-year, achieving net revenue of $74 million. Modern Oral gross revenue was $94 million, up 114% year-over-year.
Performance was driven by continued brick-and-mortar expansion in ALP, as well as momentum in large chains for FRE. For the quarter, Modern Oral accounted for 49% of consolidated net sales, up from 31% a year ago. Heritage Stoker's brands net revenue increased 3% year-over-year to $39 million for the quarter, driven by continued share growth in MST that was partially offset by anticipated declines in loose leaf. Stoker's gross profit increased 42% to $64 million. Gross margin decreased 416 basis points to 56%. Zig-Zag segment net sales were down 15% year-over-year to $37 million for the quarter. Zig-Zag gross profit decreased 16% to $21 million, and gross margin was 57%, which was essentially unchanged from last year. Onto liquidity and capital allocation. Third quarter free cash flow was $3.5 million, and we ended the quarter with $251 million of cash.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
9 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
